Raiffeisen Bank International’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Raiffeisen Bank International's CRL Position: Q2 2026 in Review
Raiffeisen Bank International increased its Charles River Laboratories (CRL) stake by 9.1% in Q2 2026, buying an estimated $89K and bringing the position to 6,000 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #381.
Raiffeisen Bank International first reported a position in CRL in Q1 2026 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Raiffeisen Bank International held 6,000 shares of Charles River Laboratories worth $1.35M as of Q2 2026.
- Raiffeisen Bank International bought 500 Charles River Laboratories shares in Q2 2026, an estimated $89K.
- Charles River Laboratories made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #381 holding.
- Raiffeisen Bank International first reported a position in Charles River Laboratories in Q1 2026 and has held it in 2 quarters since.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.